SK287410B6 - Použitie fibrátov na prípravu lieku - Google Patents

Použitie fibrátov na prípravu lieku Download PDF

Info

Publication number
SK287410B6
SK287410B6 SK131-2003A SK1312003A SK287410B6 SK 287410 B6 SK287410 B6 SK 287410B6 SK 1312003 A SK1312003 A SK 1312003A SK 287410 B6 SK287410 B6 SK 287410B6
Authority
SK
Slovakia
Prior art keywords
heart
ventricular
pressure
aortic
treatment
Prior art date
Application number
SK131-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK1312003A3 (en
Inventor
Arduino Arduini
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of SK1312003A3 publication Critical patent/SK1312003A3/sk
Publication of SK287410B6 publication Critical patent/SK287410B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK131-2003A 2000-08-01 2001-07-20 Použitie fibrátov na prípravu lieku SK287410B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000433A IT1317885B1 (it) 2000-08-01 2000-08-01 Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.
PCT/IT2001/000390 WO2002009682A2 (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure

Publications (2)

Publication Number Publication Date
SK1312003A3 SK1312003A3 (en) 2003-06-03
SK287410B6 true SK287410B6 (sk) 2010-09-07

Family

ID=11454866

Family Applications (1)

Application Number Title Priority Date Filing Date
SK131-2003A SK287410B6 (sk) 2000-08-01 2001-07-20 Použitie fibrátov na prípravu lieku

Country Status (18)

Country Link
US (2) US20030176499A1 (pt)
EP (1) EP1305020B1 (pt)
JP (1) JP2004505037A (pt)
KR (1) KR100844190B1 (pt)
CN (1) CN1798554A (pt)
AT (1) ATE330597T1 (pt)
AU (2) AU2001277686B2 (pt)
BR (1) BR0112874A (pt)
CA (1) CA2415042C (pt)
CY (1) CY1106318T1 (pt)
DE (1) DE60120985T2 (pt)
ES (1) ES2267796T3 (pt)
IT (1) IT1317885B1 (pt)
MX (1) MXPA03000900A (pt)
PL (1) PL365040A1 (pt)
PT (1) PT1305020E (pt)
SK (1) SK287410B6 (pt)
WO (1) WO2002009682A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003208238A1 (en) * 2002-03-11 2003-09-22 TAYLOR, , Carla Use of ppar alpha agonists for the treatment of vascular and renal diseases
CN100347262C (zh) * 2003-11-13 2007-11-07 同济大学 一种水溶性建筑粘结剂及其制备方法
JP5317919B2 (ja) * 2009-10-05 2013-10-16 花王株式会社 Ｇｉｐ上昇抑制剤の評価又は選択方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208203A1 (es) * 1974-09-10 1976-12-09 Cortial Proceso para la preparacion de acido p-trialquilsilil benzoico y derivados del mismo
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4463013A (en) * 1982-04-09 1984-07-31 The Upjohn Company Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs
DE3807895A1 (de) 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
WO1998005331A2 (en) * 1996-08-02 1998-02-12 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
WO1999005331A1 (en) * 1997-07-22 1999-02-04 Olin Corporation Copper alloy having magnesium addition
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
GB0002667D0 (en) * 2000-02-04 2000-03-29 Glaxo Group Ltd medicamesnts
US7352911B2 (en) * 2003-07-31 2008-04-01 Hewlett-Packard Development Company, L.P. Method for bilateral filtering of digital images

Also Published As

Publication number Publication date
WO2002009682A3 (en) 2002-04-18
KR100844190B1 (ko) 2008-07-04
PL365040A1 (en) 2004-12-27
DE60120985T2 (de) 2006-12-21
WO2002009682A2 (en) 2002-02-07
MXPA03000900A (es) 2003-10-06
IT1317885B1 (it) 2003-07-15
DE60120985D1 (de) 2006-08-03
US20090221701A1 (en) 2009-09-03
CY1106318T1 (el) 2011-10-12
CA2415042A1 (en) 2002-02-07
EP1305020B1 (en) 2006-06-21
CN1798554A (zh) 2006-07-05
AU7768601A (en) 2002-02-13
ITRM20000433A1 (it) 2002-02-01
PT1305020E (pt) 2006-10-31
US20030176499A1 (en) 2003-09-18
EP1305020A2 (en) 2003-05-02
ES2267796T3 (es) 2007-03-16
ITRM20000433A0 (it) 2000-08-01
AU2001277686B2 (en) 2006-07-20
JP2004505037A (ja) 2004-02-19
SK1312003A3 (en) 2003-06-03
BR0112874A (pt) 2003-07-01
CA2415042C (en) 2009-06-23
ATE330597T1 (de) 2006-07-15
KR20030041953A (ko) 2003-05-27

Similar Documents

Publication Publication Date Title
EP2793876B1 (en) Pharmaceutical compositions comprising glitazones and nrf2 activators
RU2214233C2 (ru) Препараты ранолазина с пролонгированным действием
DK1919458T5 (en) Enteric-coated cysteamine, cystamine and derivatives thereof
JP5249388B2 (ja) 糖尿病の治療及び予防のためのフタリド誘導体の使用
JP5519906B2 (ja) 肝臓疾患の支持療法
Plänitz Comparison of moxonidine and clonidine HCl in treating patients with hypertension
CA2406067A1 (en) Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
US20090221701A1 (en) Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
JP2000513341A (ja) 血管拡張剤を使用する肝疾患および類似の徴候の治療法
AU2001277686A1 (en) Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
JP2769217B2 (ja) 心臓状態の処置のためのプロパフェノン及びキニジンの持効性組成物
JP3502951B2 (ja) 高脂血症治療剤
EP1150669A1 (en) L-arginine based formulations for treating diseases and methods of using same
TW201334776A (zh) 醫藥組成物
US20150133507A1 (en) Pharmaceutical compositions comprising glitazones and nrf2 activators
JP2021075533A (ja) イソチオシアネート系化合物の使用
US20070072910A1 (en) Compositions and methods for lowering plasma concentrations of low density lipoproteins in humans
IL310994A (en) Preparations and methods for preventing or reducing the risk of metabolic syndrome
AU2005235436B2 (en) Supportive treatment of liver disease
Parmley et al. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110720